Specialized Medical Company (TADAWUL:4019)

TADAWUL:4019 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,538	1,438	1,368	1,209	1,053
Revenue Growth (YoY)	7.00%	5.11%	13.18%	14.77%	21.44%
Cost of Revenue	1,157	1,077	1,019	930	824.89
Gross Profit	381.59	361.06	348.96	278.66	228.24
Selling, General & Admin	146.6	130.59	134.38	150.91	159.04
Operating Expenses	146.6	130.59	134.38	150.91	159.04
Operating Income	234.99	230.47	214.58	127.75	69.2
Interest Expense	-42.47	-45.17	-48.46	-29.82	-18.89
Other Non Operating Income (Expenses)	19.36	8.35	8.52	9.13	8.98
EBT Excluding Unusual Items	211.87	193.66	174.65	107.05	59.29
Gain (Loss) on Sale of Assets	60.63	-	0.05	0.06	-
Pretax Income	272.5	193.66	174.7	107.12	59.29
Income Tax Expense	6.27	8.44	6	4.15	3.32
Net Income	266.23	185.22	168.7	102.96	55.97
Net Income to Common	266.23	185.22	168.7	102.96	55.97
Net Income Growth	43.74%	9.79%	63.84%	83.97%	21.62%
Shares Outstanding (Basic)	250	250	85	85	85
Shares Outstanding (Diluted)	250	250	85	85	85
Shares Change (YoY)	-	194.12%	-	-	-
EPS (Basic)	1.06	0.74	1.98	1.21	0.66
EPS (Diluted)	1.06	0.74	1.98	1.21	0.66
EPS Growth	43.74%	-62.67%	63.84%	83.97%	21.62%
Free Cash Flow	228.28	289.52	160.53	116.6	-159.38
Free Cash Flow Per Share	0.91	1.16	1.89	1.37	-1.88
Gross Margin	24.80%	25.11%	25.51%	23.05%	21.67%
Operating Margin	15.27%	16.03%	15.69%	10.57%	6.57%
Profit Margin	17.30%	12.88%	12.33%	8.52%	5.31%
Free Cash Flow Margin	14.84%	20.14%	11.73%	9.65%	-15.13%
EBITDA	297.44	288.94	273.08	202.59	141.55
EBITDA Margin	19.33%	20.10%	19.96%	16.76%	13.44%
D&A For EBITDA	62.46	58.47	58.49	74.85	72.35
EBIT	234.99	230.47	214.58	127.75	69.2
EBIT Margin	15.27%	16.03%	15.69%	10.57%	6.57%
Effective Tax Rate	2.30%	4.36%	3.44%	3.88%	5.60%
Advertising Expenses	15.99	8.95	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.